IconOVir Bio
Biotechnology ResearchView the employees at
IconOVir Bio-
Robert Quesenberry Clinical Development Operations Leader
-
Oakland, California, United States
-
Rising Star
-
Rising Star
Mark Chao physician-scientist, biotech executive, entrepreneur-
Stanford
-
Top 5%
Justin O. Principal Research Associate at IconOVir Bio-
San Diego, California, United States
-
Top 10%
Overview
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
-